ACP: Guidance Provided for Use of Cannabis in Chronic Noncancer Pain Management
By Elana Gotkine HealthDay Reporter
MONDAY, April 7, 2025 -- In a best practice guideline issued by the American College of Physicians and published online April 4 in the Annals of Internal Medicine, advice is presented for clinicians regarding the benefits and harms of cannabis or cannabinoids for the management of chronic noncancer pain. The guideline was published to coincide with the Internal Medicine Meeting, the annual meeting of the American College of Physicians, held from April 3 to 5 in New Orleans.
Devan Kansagara, M.D., from the Oregon Health & Science University in Portland, and colleagues developed best practice advice to inform clinicians about the benefits and harms of cannabis or cannabinoids in the management of chronic noncancer pain.
According to the guideline, when patients are considering whether to start or continue to use cannabis or cannabinoids to manage their chronic noncancer pain, clinicians should counsel patients about the benefits and harms of such use. Young adult and adolescent patients, patients with current or past substance use disorder, patients with serious mental illness, and frail patients and those at risk for falling should be counseled that the harms of cannabis or cannabinoid use for chronic noncancer pain are likely to outweigh the benefits. In patients who are pregnant, breastfeeding, or actively trying to conceive, clinicians should advise against starting or continuing to use cannabis or cannabinoids to manage chronic noncancer pain. Patients should also be advised against use of inhaled cannabis to manage chronic noncancer pain.
"Clinicians are best positioned to provide evidence-based information about the benefits and harms most relevant to an individual patient's needs and comorbidities to enable patients to make informed decisions about starting or continuing cannabis or cannabinoid use for chronic noncancer pain," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-08 06:00
Read more

- Study Finds Sharp Rise in Dangerous Strep Infections
- BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program
- BioArctic Receives Orphan Drug Designation for Exidavnemab the US
- Increasing Sleepiness Linked to Dementia Risk in Oldest Old Women
- Sarepta Therapeutics Shares Safety Update on Elevidys
- ACC: Bilateral Oophorectomy Linked to Increased Risk for Heart Failure
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions